Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
09/21/2006 | US20060211656 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
09/21/2006 | US20060211099 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols |
09/21/2006 | US20060211045 Fluorescently tagged ligands |
09/21/2006 | US20060210896 Aromatic amine-based charge transport materials having an N,N-divinyl group |
09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
09/21/2006 | CA2599551A1 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests |
09/21/2006 | CA2599478A1 Process for the purification of duloxetine hydrochloride |
09/21/2006 | CA2599475A1 Pure duloxetine hydrochloride |
09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
09/20/2006 | CN1835941A Acene-thiophen semiconductors |
09/20/2006 | CN1835917A Therapeutic agents |
09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
09/20/2006 | CN1276303C Acid generating agent, and radiation-sensitive resin composition |
09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
09/19/2006 | US7109356 of [2-(2-thienyl)ethylamino](2-halogenophenyl)acetamides of general formula by using basic compounds |
09/19/2006 | US7109355 Containing thiophene compound; coupling to polymer matrix |
09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
09/19/2006 | US7109243 Inhibitors of cathepsin S |
09/19/2006 | US7109239 for oral administration using sustained release dosage forms; baclofen and baclofen analogs |
09/19/2006 | CA2255664C Selenophene anti-tumor agents |
09/14/2006 | WO2006096809A1 Crystal forms of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine oxalate and the preparation thereof |
09/14/2006 | WO2006095634A1 Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same |
09/14/2006 | WO2006095205A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
09/14/2006 | WO2006094667A1 Method for the representation of 3,3,4,4-tetrachlorotetrahydrothiophene-1,1-dioxide |
09/14/2006 | WO2006094663A1 Process for preparing 3,4-dichlorotetrahydrothiophene 1,1-dioxide |
09/14/2006 | WO2006071868A3 Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
09/14/2006 | US20060205956 Salt formation |
09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
09/14/2006 | US20060205748 Heterocyclic diamide invertebrate pest control agents |
09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
09/14/2006 | US20060205726 e.g. 2-(2-{3-acetoxy-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetoxymethyl)-2-phenylmalonic acid diethyl ester; microsomal triglyceride transfer protein inhibitor in small intestine; antihyperlipidemic, antidiabetic agent; arteriosclerosis, coronary artery diseases, obesity |
09/14/2006 | DE102005011230A1 Verfahren zur Darstellung von 3,4-Dichlortetrahydrothiophen-1,1-dioxid A process for the preparation of 3,4-Dichlortetrahydrothiophen-1,1-dioxide |
09/14/2006 | DE102005011229A1 Verfahren zur Darstellung von 3,3,4,4-Tetrachlortetrahydrothiophen-1,1-dioxid A process for the preparation of 3,3,4,4-tetrachlorotetrahydrothiophene-1,1-dioxide |
09/14/2006 | CA2600475A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
09/13/2006 | EP1700844A1 Phthalic acid diamide derivatives, agricultural and horticultural insecticides and a method for application of the insecticides |
09/13/2006 | EP1699752A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
09/13/2006 | EP1419148B1 M-aminophenol derivatives and colouring agents containing them |
09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
09/13/2006 | EP1406869B1 Taxol enhancer compounds |
09/13/2006 | EP0979821B1 Tricyclic compounds |
09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
09/13/2006 | CN1830975A Improved seal swell agent and process therefor |
09/13/2006 | CN1830974A Multiple substituted propylamine compounds and its prepn. method |
09/13/2006 | CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain |
09/13/2006 | CN1275101C Electric photographic photoreceptor, imaging processing cartidge and electric photographic device |
09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
09/12/2006 | US7105707 By reacting an aryl nitrile with an alkynylzinc compound, a bis-alkynylzinc compound, or an alkynylmagnesium compound, in the presence of a nickel/phosphine catalyst. |
09/12/2006 | US7105702 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
09/12/2006 | US7105683 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates |
09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
09/12/2006 | US7105513 Cardiovascular disorders; strokes; hypotensive agents |
09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
09/08/2006 | WO2006093124A1 Free radical scavenger containing semicarbazide derivative |
09/08/2006 | WO2006067414A3 Glycine transport inhibitors |
09/08/2006 | WO2005117907A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
09/07/2006 | US20060199857 Therapeutic agents |
09/07/2006 | US20060199856 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
09/07/2006 | US20060199848 Ion channel modulating activity II |
09/07/2006 | US20060199845 Thiophene compounds for inflammation and immune-related uses |
09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
09/07/2006 | DE102005009440A1 Thienopyridinderivate Thienopyridine derivatives |
09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
09/06/2006 | EP1698618A1 Benzamide derivative |
09/06/2006 | EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
09/06/2006 | EP1697309A2 Benzoyl-substituted phenylalanine amides |
09/06/2006 | EP1697304A1 Peroxisome proliferator activated receptor modulators |
09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
09/06/2006 | CN1829939A Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom |
09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
09/06/2006 | CN1829673A Synthesis of alpha,beta,beta-trifluorostyrene via in-situ for mation or trifluorovinyl metal halide |
09/06/2006 | CN1273511C Method of preparing a polymer, method of preparing a compound, compounds, polymers, and method for manufacturing and electronic device |
09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
09/06/2006 | CN1273444C Dipeptide nitriles |
09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
09/05/2006 | US7101998 Fused ring compounds, and their use as cationic photoinitiators |
09/05/2006 | US7101915 P-terphenyl compounds |
09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
09/05/2006 | US7101906 2,3,4-substituted cyclopentanones as therapeutic agents |
09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
09/05/2006 | US7101904 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
09/05/2006 | US7101900 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
08/31/2006 | WO2006090928A1 Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |